DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Appropriations History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Appropriations | ₹13,977 Cr | ₹12,559 Cr | ₹11,812 Cr | ₹1,055,817 Cr | ₹7,779 Cr |
What is the latest Appropriations of DIVIS LABORATORIES ?
| Year | Appropriations |
|---|---|
| Mar2026 | ₹13,977 Cr |
| Mar2025 | ₹12,559 Cr |
| Mar2024 | ₹11,812 Cr |
| Mar2023 | ₹1,055,817 Cr |
| Mar2022 | ₹7,779 Cr |
How is Appropriations of DIVIS LABORATORIES Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2026 | ₹13,977 Cr | 11.29 | |
| Mar2025 | ₹12,559 Cr | 6.32 | |
| Mar2024 | ₹11,812 Cr | -98.88 | |
| Mar2023 | ₹1,055,817 Cr | 13,473.41 | |
| Mar2022 | ₹7,779 Cr | - | |
Compare Appropriations of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹192,701.2 Cr | 7.1% | 9% | 4.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.8% | 8.3% | 17.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | 2% | 12.1% | 49.6% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.7% | 4.1% | -3.6% | Stock Analytics | |
| MANKIND PHARMA | ₹102,896.0 Cr | 0.8% | 8% | 0.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.7% | -4.2% | -3.1% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 7.1% |
9% |
4.2% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses